Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

467

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Pain
Interventions
DRUG

ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride ER)

capsules, available dosage strengths 20, 30, 40, 50, 60, 80, and 100 mg morphine sulfate with 4% by weight naltrexone hydrochloride given once or twice daily

Trial Locations (58)

10550

Arthur Elkind, MD, Mount Vernon

16684

Lawrence Levinson, MD, Tipton

24018

Richard Eckert, MD, Roanoke

27103

Richard Rauck, MD, Winston-Salem

Thomas Littlejohn III, MD, Winston-Salem

28210

Patrick Box, MD, Charlotte

29651

William Travis Ellison, MD, Greer

30060

Arnold Weil, Marietta

30066

Marvin Tark, Marietta

30513

Raymond Tidman, MD, Blue Ridge

32174

Diego Torres II, MD, Ormond Beach

32257

Orlando Florete, MD, Jacksonville

33013

Roberto Rodriquez, MD, Hialeah

33324

Martin Hale, MD, Plantation

33484

Steven Croft, MD, Delray Beach

33613

Mary Stedman, MD, Tampa

33702

Margarita Nunez, MD, St. Petersburg

33770

Miguel Trevino, MD, Largo

34741

Michael Link, MD, Kissimmee

35244

Michael Gibson, MD, Birmingham

37920

William Smith, MD, Knoxville

38358

Lee Carter, MD, Milan

43623

Robert Kalb, MD, Toledo

45227

Bruce Corser, MD, Cincinnati

45242

Gregory Gottschlich, MD, Cincinnati

47714

Steven Elliott, MD, Evansville

48602

Rebecca Baumbach, MD, Saginaw

50265

John Peppin, DO, West Des Moines

59802

Randale Sechrest, MD, Missoula

60616

Azazuddin Ahmed, MD, Chicago

61614

Jenecsis Castro-Skoglund, MD, Peoria

63031

Mel Lucas, MD, Florissant

63141

Anthony Margherita, MD, St Louis

68134

John Jacobson, MD, Omaha

71103

Randall Brewer, MD, Shreveport

73116

Tanna Shaw, MD, Oklahoma City

75080

Andrew Klymiuk, MD, Richardson

78217

Francis Burch, MD, San Antonio

78229

Suzanne Gazda, MD, San Antonio

78705

Walter Chase, MD, Austin

84106

Webster Lynn, MD, Salt Lake City

85027

Steven Siwek, MD, Phoenix

85032

Michael Loes, MD, Phoenix

85282

Allan Soo, MD, Tempe

85741

Leah Schmidt, DO, Tucson

87108

Barbara McGuire, MD, Albuquerque

89014

James Meli, DO, Henderson

89106

Stephen Miller, MD, Las Vegas

89123

Vrijendra Kumar, MD, Las Vegas

90211

Adam Karnes, MD, Beverly Hills

92801

Steve Sitar, MD, Anaheim

92804

Robert Burton, MD, Anaheim

93311

Arturo Palencia, MD, Bakersfield

95628

Douglas Haselwood, MD, Fair Oaks

97401

Joseph Dunn, MD, Eugene

02747

David Miller, MD, North Dartmouth

01103

Adnan Dahdul, MD, Springfield

08043

Christopher Colopinto, MD, Voorhees Township

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00415597 - Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain | Biotech Hunter | Biotech Hunter